Sundar PichaiSundar Pichai earned $164M in 2023
K

Benjamin L. Palleiko

CEO of KalVista Pharmaceuticals

Economy Sector

Healthcare

Current Tenure

1 year 10 months (Mar 2023 - Present)

Previous Experience

Unknown

Benjamin L. Palleiko is the CEO of KalVista Pharmaceuticals, a biotech company focusing on innovative treatments. He stepped into this role on March 6, 2023, after serving as the President and Chief Financial Officer. His journey in the biotech scene...

Year

2023

Total Compensation

$707.10K

Salary

$514.50K

Board Justification

We seek to ensure that the total compensation paid to our executive officers is reasonable and competitive, structured around the achievement of individual performance and near-term corporate targets as well as long-term business objectives.

Bonus

$180.08K

Board Justification

The amount reported in the Bonus column represents the annual cash discretionary bonuses earned by our NEOs pursuant to the achievement of certain Company and individual performance objectives.

Other

$12.53K

Board Justification

The amounts reported in the All Other Compensation column consist of Company contributions to the 401(k) Plan.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock was reported as vested in 2023.

Performance Metrics

The performance objectives for our executive officers do not have specific financial or corporate targets associated with them.